Cipla Ltd.

BSE: 500087 | NSE: CIPLA

Large Cap | Pharmaceuticals & Drugs

1438.75

-2.95 (-0.20%)

< Home < Back

Cipla informs about quarterly statement of investor complaints

Date: 21-07-2016

Cipla has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.